Mary J. Mullany concentrates her practice in the areas of securities disclosure and offerings, mergers and acquisitions, corporate financing (public and private), executive compensation, corporate governance, pharmaceutical and life sciences licensing and collaborations, general corporate law, business counseling, and health care law.
Mary has worked most recently on sophisticated merger and acquisition transactions for publicly traded companies, and on securities offerings including an initial public offering and other capital raising transactions. She counsels public and private companies in the areas of corporate governance, disclosure obligations, executive compensation, and financing alternatives. Much of Mary's work with pharmaceutical, biotechnology, and life science companies focuses on mergers and acquisitions, securities offerings, and other corporate financing, and on licensing agreements, including collaborations and joint ventures.
Before becoming an attorney, Mary was a registered nurse with experience in critical care and risk management.
- Represent a privately held immuno-oncology company with four products in clinical trials that raised $60 million in 2020-2021 and is working towards an initial public offering.
- Represent a privately held company making multiple acquisitions nationwide.
- Represent four public reporting companies with securities disclosure and compliance work and corporate governance.
Pro Bono Experience
Mary is a frequent presenter in legal education courses. She was co-chair and faculty for PLI's (Practising Law Institute) popular "Annual Disclosure Documents" securities law course every year from 2008 until the program was discontinued in 2019. She has also given multiple speaking engagements and presented at webinars on securities law updates and executive compensation, including the Dodd-Frank Act executive compensation provisions.
Co-author, "Ballard Spahr Gears Up for a Busy 2019," M&A Magazine, January 2019
"Virtual-Only Shareholder Meetings," The Review of Securities & Commodities Regulation, Vol. 51, No. 5, March 7, 2018
"Shareholder Approval of Equity Plans – Current Considerations," The Review of Securities & Commodities Regulation, Vol. 49, No. 8, April 20, 2016
"It's Time for Board Succession Planning to Take Hold," The Legal Intelligencer, March 24, 2015
Villanova University School of Law (J.D. 1993, magna cum laude)
Articles Editor, Villanova Law Review; Member, Order of the Coif
Widener University (M.S.N. 1988)
University of Pennsylvania (B.S.N. 1979)